Creative Details

Quality Score: 7/10

The advertisement promotes BOTOX as a treatment option for chronic migraines, highlighting its approved use and safety information.

Creative Information

CID:ffec933c-a41f-4f42-8139-38f1cf9c2b54
CRID:25_o32c4sbl
Domain:botoxchronicmigraine.com
Seat:TTD
Size:160x600
Bid:$1.74
Timestamp:11/13/2025, 3:25:32 PM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess11/13/2025, 4:46:51 PM8.26s
    adomain_analysissuccess11/13/2025, 4:46:20 PM4.62s
    adomain_capturesuccess11/13/2025, 6:44:46 PM0.16s
    ad_rendersuccess11/13/2025, 4:46:43 PM31.30s
    brand_mappingsuccess11/13/2025, 3:25:32 PM0.11s

    Analysis Results

    Ad Format: banner

    Brands: BOTOX®

    Size:160x600
    Data Transferred:1522.14 KB
    Render Time:8.18 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    • Society (IAB14)
    Creative Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Cosmetic Medical Services (1383)
    Domain Inferred IAB Categories:
    • Health & Fitness (IAB7)
    Domain Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Cosmetic Medical Services (1383)
    • Pharmaceuticals (1473)
    Landing Page:
    Total Ad Size:1543.31 KB
    Requests Made:
    URLSize (KB)
    https://cdn.doubleverify.com/dvbm.js527.94
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js222.95
    https://s0.2mdn.net/ads/studio/Enabler.js153.28
    https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js116.69
    https://ad.doubleclick.net/ddm/adj/N1670579.3958515PMPRECISIONTHETR/B32740655.408115734;dc_ver=106.314;dc_eid=40004001;sz=160x600;u_sd=1;gdpr=0;nel=1;dvs1=1;dvs10=eciddfn;dvs11=kargo;dvs12=doubleverify-vd2iab-70;dvs13=mail.aol.com;dvs15=102;dvs16=o32c4sbl;dvs17=8727;dvs2=mail.aol.com%252f;dvs3=h1dr0mj;dvs4=nvzzzs2;dvs6=df0df926-28fc-43ac-b29e-4cee7992e67e;dvs7=vymzzj8;dvs8=1;dvs9=vymzzj8;dc_adk=2027040026;ord=nnrlmz;click=https%3A%2F%2Finsight.adsrvr.org%2Ftrack%2Fclk%3Fimp%3Ddf0df926-28fc-43ac-b29e-4cee7992e67e%26ag%3Deciddfn%26sfe%3D1b4ca885%26sig%3DmrPJ-nFgcOTDJfaripi70mVUeRjXc3vjVBdSlydo7o8.%26crid%3Do32c4sbl%26cf%3D7868657%26fq%3D0%26t%3D1%26td_s%3Dmail.aol.com%26rcats%3Doj8%26mste%3D%26mfld%3D2%26mssi%3D%26mfsi%3D%26sv%3Dkargo%26uhow%3D91%26agsa%3D%26wp%3D1.73925%26rgz%3D19082%26dt%3DPC%26osf%3DWindows%26os%3DWindows10%26br%3DChrome%26svpid%3D8727%26rlangs%3Den%26mlang%3D%26did%3D%26rcxt%3DOther%26tmpc%3D11.210000000000036%26vrtd%3D%26osi%3D%26osv%3D%26daid%3D%26dnr%3D0%26vpb%3D%26crrelr%3D%26npt%3D%26cc%3D2~KLUv_WMdqREMowNlFwCjY4G3XFtUbk1Uji0qx0XKisHL5YYl68RYCSaUzuxW9LAyqQe0A6AQZmbAFKFy1b0VoUJGDKIEIRKMeaTDSigA8t5_vdTDxzu8uhLR1OPRgjEzkkhncNZSgWa7L2tWd-bz4tG4Wb9LuWd3QLrIT4N9viXKNw9ngUKxaZmZTjvF8aMz2UOhyPhY73xLKtl922ZBLqvS5xs-xaRcZB3UKsNy2f7NvOgg13KqI5PJqjrfL74StWg5dpcu92DUHrNWnVzZJJOHnfKm1Tw7NiU769GMYzus1w5IJ5XGprJnbsmMuHCHZS57vSg9W5nSIxjSJ9b7V2T1C9r06zIrkguWP8t-TbM62iu9tvYRiMu_MGsFYplhP66dzj_esNXnqyqrzmhy7Ac7y6M7re5Xz0j4C-m1lJc1L6_-uHKv5_NvUnkdd_u1rWmwJLS-lcYuNO5vz8Zkux_UFsF-sBWhBj44bzcIKHGHQdfOhB_b9a-T8f6n5_m-Z1q_fb-GdbafM1AnR6YrHSQWe7AgcXLihNWrNYdHoEyYoHD5mtPjROUTC1ybXOVyudgVlHBszCdM7WNlFc5LAlnG4TzWfQnMPx_nu-3ruc7_8Vg3_7Ks62M6xnVZwhonGmnOvUrz8hy1OpMSZGSS1wIlYDgteb-KBwGiHFtIRSJW3h4UDp4COdi0gY93ef5hmP91_dcKQvzA5SIHEU-rEGeOemyfga38SfOo_4rANHa2UOyNhkoGo-vWdn5l3DwpRX5sgMxCqYVeucfg5Iwck4jlFXV3fzz1LNB_5iYg6n40eJp4DZ5VtbqBF7ltsx84cxBFqFrhzzvGCGwE_EMkn0-VZICkx0Z5yxwcYBrc1BA1kUlMKwzprUYlidllKpSoqYO31bslLPma7sDV4YjFbStRuTHIvY1j6qhmCIo528z5c7zpUeCFdBomWnLCker8_hlABYRQM2XVfyP9i-nGFoP8Rl5paxQAiLVXKVbz6YwHItxuc2JtbLAi%26dur%3D1~KLUv_WMFoCgk_QAVBQDTRxsXmKCIFXxUF1Dh-X20U-ff64cS9wy7xhTOvzvcPnefzo4lVW8ssSHpGMw_GSk5ZdCbmgQwyRlvARzt5tV4Bk-xDHpTEwEmieE5APbqSp6LFNLSkpOWnC1bfJJIxBBG3gynemOJrenu3cVopmEQEvwHvFsIfkrBgoO26THwqOcy3iollD6l4Ui_FC7Jxx4R3aA9fn6ox91AaHcgHyVtJAc.%26durs%3DaqunGV%26bdc%3D131%26uidd%3DESLxGebW1wbEz_OMh75ngS45yRyz-crkfmmP9JEs9B5i2iPQ%26idl%3DXY3007qR0Q35E-xAo9ZSfVgolshsDDt07Ne-AJETjvFtwHf2A%26testid%3Diavc1%2520%26fpa%3D366%26pcm%3D3%26ict%3DEthernet%26said%3D9bb40de6-0927-45ee-9b1b-7a43eb7ab773%26auct%3D1%26tail%3D1%26r%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=whWhiZuhFV;gcsr=m;stc=1;chaa=1;sttr=42;prcl=s107.67
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://ep1.adtrafficquality.google/bg/3AskVp3fsf8-NwDrHwfwABhIV_lOSIPikrDbTygANqw.js52.60
    https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js42.74
    https://choices.truste.com/ca?pid=publicishealthmedia01&aid=abbvie01&cid=32740655_242504043_408115734&js=st022.83
    https://s0.2mdn.net/sadbundle/3395371586802137219/160x600/assets/js/perfect-scrollbar.min.js19.09

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1Creative Screenshot 2Creative Screenshot 3